Abstract
Deletions of the long arm of chromosome 20 have been reported in a wide range of myeloid disorders and may reflect loss of critical tumor suppressor gene(s). To identify such candidate genes, 65 human myeloid cell line DNAs were screened by polymerase chain reaction (PCR) for evidence of allelic loss at 39 highly polymorphic loci on the long arm of chromosome 20. A mono-allelic pattern was present in eight cell lines at multiple adjacent loci spanning the common deleted regions (CDRs) previously defined in primary hematological samples, suggesting loss of heterozygosity (LOH) at 20q. Fluorescence in situ hybridization (FISH) was then performed using a series of yeast artificial chromosomes (YACs) ordered in the CDR, and in five of eight cell lines, the deletions resulted from cytogenetically detectable whole chromosomal loss or large interstitial deletion, whereas in another cell line deletion was associated with an unbalanced translocation. LOH in the CMK megakaryocytic cell line, which has a hypotetraploid karyotype, was associated with a der(20)t(1;20)(q32;q12)x2 leading to complete deletion of the CDR. Three additional unbalanced translocations were found within the CDR and all three breakpoints mapped to a single YAC. We then used a series of P1 artificial chromosomes (PACs) spanning this YAC clone, and two PACs produced ‘split’ signals suggesting that they each span one of these breakpoints. Exon trapping using PACs that overlap the breakpoint regions yielded portions of six genes and evaluation of these genes as candidate tumor suppressor genes is underway. The limited information available about these genes suggests that the h-l(3)mbt gene is the most attractive candidate.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aatola M, Armstrong E, Teerenhovi L, Borgstrom GH . 1992 Cancer Genet. Cytogenet. 62: 75–80
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ . 1990 J. Mol. Biol. 215: 403–410
Asimakopoulos FA, White NJ, Nacheva E, Green AR . 1994 Blood 84: 3086–3094
Asimakopoulos FA, Gilbert JG, Aldred MA, Pearson TC, Green AR . 1996 Blood 88: 2690–2698
Asimakopoulos FA, Green AR . 1996 Br. J. Haematol. 95: 219–226
Bench AJ, Aldred MA, Humphray SJ, Champion KM, Gilbert JG, Asimakopoulos FA, Deloukas P, Gwilliam R, Bentley DR, Green AR . 1998 Genomics 49: 351–362
Bench AJ, Nacheva EP, Hood TL, Holden JL, French L, Swanton S, Champion KM, Li J, Whittaker P, Stavrides G, Hunt AR, Huntly BJ, Campbell LJ, Bentley DR, Deloukas P, Green AR . 2000 Oncogene 19: 3902–3913
Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL . 1983 Nature 305: 779–784
Deloukas P, Schuler GD, Gyapay G, Beasley EM, Soderlund C, Rodriguez-Tome P, Hui L, Matise TC, McKusick KB, Beckmann JS, Bentolila S, Bihoreau M, Birren BB, Browne J, Butler A, Castle AB, Chiannilkulchai N, Clee C, Day PJ, Dehejia A, Dibling T, Drouot N, Duprat S, Fizames C, Fox S, Gelling S, Green L, Harrison P, Hocking R, Holloway E, Hunt S, Keil S, Lijnzaad P, Louis-Dit-Sully C, Ma J, Mendis A, Miller J, Morisette J, Muselet D, Nusbaum HC, Peck A, Rozen S, Simon D, Slonim DK, Staples R, Stein LD, Stewart EA, Suchard MA, Thangarajah T, Vega-Czarny N, Webber C, Wu X, Hudson J, Auffray C, Nomura N, Sikela JM, Polymeropoulos MH, James MR, Lander ES, Hudson TJ, Myers RM, Cox DR, Weissenbach J, Boguski MS, Bentley DR . 1998 Science 282: 744–746
Dewald GW, Wright PI . 1995 Semin. Oncol. 22: 341–354
Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J . 1996 Nature 380: 152–154
Fountain JW, Wallace MR, Bruce MA, Seizinger BR, Menon AG, Gusella JF, Michels VV, Schmidt MA, Dewald GW, Collins FS . 1989 Science 244: 1085–1087
Hirama T, Koeffler HP . 1995 Blood 86: 841–854
Hollings PE, Rasman I, Beard ME . 1994 Blood 83: 305–306
Hollings PE, Benjes SM, Rosman I, Fitzgerald PH . 1995 Cancer Genet. Cytogenet. 79: 32–35
Knuutila S, Teerenhovi L, Larramendy ML, Elonen E, Franssila KO, Nylund SJ, Timonen T, Heinonen K, Mahlamaki E, Winqvist R, Ruutu T . 1994 Genes Chrom. Cancer 10: 95–102
Kurtin PJ, Dewald GW, Shields DJ, Hanson CA . 1996 Am. J. Clin. Pathol. 106: 680–688
Koga H, Matsui S, Hirota T, Takebayashi S, Okumura K, Saya H . 1999 Oncogene 18: 3799–3809
Lai CH, Chou CY, Ch'ang LY, Liu CS, Lin W . 2000 Genome Res. 10: 703–713
Liu Y, Hermanson M, Grander D, Merup M, Wu X, Heyman M, Rasool O, Juliusson G, Gahrton G, Detlofsson R, Nikiforova N, Buys C, Soderhall S, Yankovsky N, Zabarovsky E, Einhorn S . 1995 Blood 86: 1911–1915
Margolis RL, Abraham MR, Gatchell SB, Li SH, Kidwai AS, Breschel TS, Stine OC, Callahan C, McInnis MG, Ross CA . 1997 Hum. Genet. 100: 114–122
Mertens F, Johansson B, Heim S, Kristoffersson U, Mitelman F . 1991 Leukemia 5: 214–220
Mitelman F . 1995 Catalog of Chromosome Aberrations in Cancer Wiley Liss: New York
Mori N, Morosetti R, Lee S, Spira S, Ben-Yehuda D, Schiller G, Landolfi R, Mizoguchi H, Koeffler HP . 1997 Blood 90: 2010–2014
Nacheva E, Holloway T, Carter N, Grace C, White N, Green AR . 1995 Cancer Genet. Cytogenet. 80: 87–94
Noben-Trauth K, Copeland NG, Gilbert DJ, Jenkins NA, Sonoda G, Testa JR, Klempnauer K-H . 1996 Genomics 35: 610–612
Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA . 1994 Nature 368: 753–756
Paige AJ, Taylor KJ, Stewart A, Sgouros JG, Gabra H, Sellar GC, Smyth JF, Porteous DJ, Watson JE . 2000 Cancer Res. 60: 1690–1697
Roulston D, Espinosa R 3d, Stoffel M, Bell GI, Le Beau MM . 1993 Blood 82: 3424–3429
Sambrook J, Fritsch EF, Maniatis T . 1989 Molecular Cloning: A Laboratory Manual Cold Spring Harbor Laboratory Press
Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque AT, Rozenblum E, Weinstein CL, Bittner M, Meltzer PS, Trent JM, Yeo CJ, Hruban RH, Kern SE . 1995 Proc. Natl. Acad. Sci. USA 92: 5950–5954
Stoffel M, Le Beau MM, Espinosa R 3rd, Bohlander SF, Le Paslier D, Cohen D, Xiang KS, Cox NJ, Fajans SS, Bell CI . 1996 Proc. Natl. Acad. Sci. USA 93: 3937–3941
Strachan T, Read A . 1996 Human Molecular Genetics Wiley Liss: New York pp. 151–155
Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA, White R, O'Connell P . 1990 Cell 62: 187–192
Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS . 1990 Science 249: 181–186
Wang PW, Iannantuoni K, Davis EM, Espinosa III R, Stoffel M, Le Beau MM . 1998 Genes Chrom. Cancer 21: 75–81
Wang PW, Eisenbart JD, Espinosa III R, Davis EM, Larson RA, Le Beau MM . 2000 Genomics 67: 28–39
White NJ, Nacheva E, Asimakopoulos FA, Bloxham D, Paul B, Green AR . 1994 Blood 83: 2809–2816
Acknowledgements
We are grateful to the following investigators for providing cell lines: B Andersson, M Baumanne, H Ben-Bassat, R Berthier, B Clarkson, J Cossman, W Dai, Z Estrov, C Gambacorti, J Goldman, H Hirai, J Kao, N Komatsu, I Kubonishi, T Kudo, M Kurosawa, M Lieberman, Y Matsuo, I Miyoshi, D Morgan, J Okamura, A Rimbaldi, L Skinnider, T Tange, T Takahashi, E Thompson, M Tomonaga. We thank Hong Wu for technical assistance, Frederic Gilles and Andrew Zelenetz for their assistance and advice in pulse-field gel electrophoresis, and Ellie Park for her assistance in preparing the manuscript. This work was supported by the Gabrielle Rich Leukemia Research Fund, the Renny Saltzman Leukemia Research Fund and NIH grant RO1DK43025 (SD Nimer)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MacGrogan, D., Alvarez, S., DeBlasio, T. et al. Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell lines. Oncogene 20, 4150–4160 (2001). https://doi.org/10.1038/sj.onc.1204540
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204540
Keywords
This article is cited by
-
Detailed molecular cytogenetic characterisation of the myeloid cell line U937 reveals the fate of homologous chromosomes and shows that centromere capture is a feature of genome instability
Molecular Cytogenetics (2020)
-
Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs)
Leukemia (2008)
-
Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions
Annals of Hematology (2008)
-
Impaired maturation of myeloid progenitors in mice lacking novel Polycomb group protein MBT-1
The EMBO Journal (2005)
-
Cloning and characterization of human Src-like adaptor protein 2 and a novel splice isoform, SLAP-2-v
Oncogene (2003)